It’s been more than two years since Eli Lilly announced LillyDirect, a platform that combines telehealth and pharmacy services to provide access to Lilly’s portfolio of diabetes, migraine and obesity medications. The goal is to offer a more transparent and affordable way to access certain drugs. The platform has quickly drawn attention from both consumers and lawmakers.

To understand LillyDirect’s growth and where it’s headed, Senior Writer Anastassia Gliadkovskaya spoke with Jen Mazur, senior vice president and general manager of U.S. LillyDirect and Consumer Services.

To learn more about the topics in this episode: 
Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers
Lilly makes website to simplify access to obesity drug Zepbound, plus diabetes and migraine meds
'Abuse of power': Senators call out 'shady tactics' after investigating Pfizer, Lilly DTC platforms

 

It&rsquo;s been more than two years since Eli Lilly announced LillyDirect, a platform that combines telehealth and pharmacy services to provide access to Lilly&rsquo;s portfolio of diabetes, migraine and obesity medications. The goal is to offer a more transparent and affordable way to access certain drugs. The platform has quickly drawn attention from both consumers and lawmakers.
To understand LillyDirect&rsquo;s growth and where it&rsquo;s headed, Senior Writer Anastassia Gliadkovskaya spoke with Jen Mazur, senior vice president and general manager of U.S. LillyDirect and Consumer Services.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/telehealth/eli-lillys-launches-oral-glp-1-drug-across-us-through-lilly-direct-telehealth-providers">Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers</a></li>
<li><a href="https://www.fiercepharma.com/marketing/lilly-makes-website-simplify-access-obesity-drug-zepbound-plus-diabetes-and-migraine-meds">Lilly makes website to simplify access to obesity drug Zepbound, plus diabetes and migraine meds</a></li>
<li><a href="https://www.fiercepharma.com/marketing/senators-condemn-big-pharmas-shady-tactics-after-investigating-pfizer-lilly-dtc-platforms">'Abuse of power': Senators call out 'shady tactics' after investigating Pfizer, Lilly DTC platforms</a></li>
</ul>
&nbsp;

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

An insider’s look at LillyDirect

Is AI in health care overhyped — or underutilized? In this sponsored episode of Podnosis, host Irena speaks with Sanjay Subramanian, SVP & Head of Healthcare Payer Business at Cognizant at Cognizant, about where artificial intelligence is delivering measurable ROI today and why many organizations struggle to scale adoption.

Sanjay explains that back‑office functions such as claims processing, prior authorization and revenue cycle management are seeing the strongest results, thanks to data‑rich workflows and clear operational metrics. He also outlines why more complex use cases, including autonomous clinical decision‑making, remain constrained by fragmented data, regulatory requirements and trust challenges.

The discussion explores common mistakes leaders make when funding AI initiatives, including chasing disconnected use cases, underestimating data readiness and focusing on pilots instead of enterprise outcomes. Looking ahead, Sanjay describes how connected intelligence, responsible AI governance and human‑in‑the‑loop models will shape the next phase of health care transformation — and why AI’s future lies in augmenting decision‑making, not replacing it.

 

Guest Bio

Sanjay Subramanian is a transformational leader with over 29 years of expertise in profit and loss management, sales and delivery across management consulting, systems integration and outsourcing. He is recognized for guiding CXO clients through strategic business decisions and digital transformation, consistently delivering measurable outcomes in challenging environments. Sanjay has led successful turnarounds, managed large teams exceeding 5000 members and originated transformative outsourcing contracts totaling over $8 billion with Fortune 100 clients. His experience spans Asia Pacific, the UK and North America, across industries including healthcare, life sciences, automotive, manufacturing, retail, energy, utilities, transportation and logistics. He has built and scaled businesses, launched new consulting capabilities and enabled cross-functional collaboration among diverse stakeholders. Sanjay brings a strong focus on client relationships and long-term value creation, supporting sustained growth across major global accounts.

Is AI in health care overhyped &mdash; or underutilized? In this sponsored episode of Podnosis, host Irena speaks with Sanjay Subramanian, SVP &amp; Head of Healthcare Payer Business at Cognizant at Cognizant, about where artificial intelligence is delivering measurable ROI today and why many organizations struggle to scale adoption.
Sanjay explains that back‑office functions such as claims processing, prior authorization and revenue cycle management are seeing the strongest results, thanks to data‑rich workflows and clear operational metrics. He also outlines why more complex use cases, including autonomous clinical decision‑making, remain constrained by fragmented data, regulatory requirements and trust challenges.
The discussion explores common mistakes leaders make when funding AI initiatives, including chasing disconnected use cases, underestimating data readiness and focusing on pilots instead of enterprise outcomes. Looking ahead, Sanjay describes how connected intelligence, responsible AI governance and human‑in‑the‑loop models will shape the next phase of health care transformation &mdash; and why AI&rsquo;s future lies in augmenting decision‑making, not replacing it.
&nbsp;
Guest Bio
Sanjay Subramanian is a transformational leader with over 29 years of expertise in profit and loss management, sales and delivery across management consulting, systems integration and outsourcing. He is recognized for guiding CXO clients through strategic business decisions and digital transformation, consistently delivering measurable outcomes in challenging environments. Sanjay has led successful turnarounds, managed large teams exceeding 5000 members and originated transformative outsourcing contracts totaling over $8 billion with Fortune 100 clients. His experience spans Asia Pacific, the UK and North America, across industries including healthcare, life sciences, automotive, manufacturing, retail, energy, utilities, transportation and logistics. He has built and scaled businesses, launched new consulting capabilities and enabled cross-functional collaboration among diverse stakeholders. Sanjay brings a strong focus on client relationships and long-term value creation, supporting sustained growth across major global accounts.

AI in health care: From hype to enterprise value (Sponsored)

As almost 1 in 4 American teens identify as LGBTQ, affirming therapy can be life-saving. Yet availability is shrinking. Access to mental healthcare for LGBTQ youth dropped from 80% to 60% from late 2023 to late 2024, according to The Trevor Project. In 2025, though 84% of LGBTQ youth wanted mental healthcare, 44% could not get it.  

In a recent collaboration between Fierce Healthcare and Uncloseted Media, Anastassia Gliadkovskaya and Sam Donndelinger dive into the barriers to mental health access for queer youth.

In this week’s episode of “Podnosis,” they discuss their reporting process and introduce listeners to trans teens and the experts featured in the project.

Read the full story at FierceHealthcare.com or UnclosetedMedia.com.

To learn more about the topics in this episode: 
The broken pipeline of mental healthcare for LGBTQ teenagers
NYU Langone Health says it received grand jury subpoena over gender-affirming care
Texas Children's Hospital agrees to launch nation's first 'detransition clinic' to settle state, DOJ investigation
Executives examine the benefit of DEI practices for building trust in healthcare

As almost 1 in 4 American teens identify as LGBTQ, affirming therapy can be life-saving. Yet availability is shrinking. Access to mental healthcare for LGBTQ youth dropped from 80% to 60% from late 2023 to late 2024, according to <a href="https://www.thetrevorproject.org/project-spark-interim-report-a-longitudinal-study/#:~:text=Sexual%2Dorientation%20discrimination%20was%20high,to%2060%25%20the%20following%20year." aria-label="Link The Trevor Project">The Trevor Project</a>. In 2025, though 84% of LGBTQ youth <a href="https://www.thetrevorproject.org/survey-2025" aria-label="Link wanted">wanted</a> mental healthcare, 44% could not get it. &nbsp;
In a recent collaboration between Fierce Healthcare and Uncloseted Media, Anastassia Gliadkovskaya and Sam Donndelinger dive into the barriers to mental health access for queer youth.
In this week&rsquo;s episode of &ldquo;Podnosis,&rdquo; they discuss their reporting process and introduce listeners to trans teens and the experts featured in the project.
Read the full story at <a href="http://fiercehealthcare.com/" aria-label="Link FierceHealthcare.com">FierceHealthcare.com</a> or <a href="https://www.unclosetedmedia.com/p/americas-broken-pipeline-of-mental" aria-label="Link UnclosetedMedia.com">UnclosetedMedia.com</a>.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/broken-pipeline-mental-healthcare-lgbtq-teenagers">The broken pipeline of mental healthcare for LGBTQ teenagers</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/nyu-langone-health-says-it-received-grand-jury-subpoena-over-gender-affirming-care">NYU Langone Health says it received grand jury subpoena over gender-affirming care</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/texas-childrens-agrees-launch-nations-first-detransition-clinic-settle-state-doj">Texas Children's Hospital agrees to launch nation's first 'detransition clinic' to settle state, DOJ investigation</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/executives-examine-benefit-dei-practices-building-trust-healthcare">Executives examine the benefit of DEI practices for building trust in healthcare</a></li>
</ul>

The broken pipeline of mental healthcare for LGBTQ teenagers

Payers and providers felt the upheaval and instability on the Affordable Care Act exchanges in the first quarter of this year.

Marketplace plans saw significant enrollment declines alongside tier shifts, while providers felt the impact in both volumes and payer mix.

Fierce Healthcare's Dave Muoio and Paige Minemyer sit down this week on “Podnosis” to break down those trends and other first-quarter throughlines, including the effect of winter storms on provider finances and signs of a rebound in Medicare Advantage.

To learn more about the topics in this episode: 
The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'
Cigna to exit ACA market, pursue strategic alternatives for eviCore unit
Universal Health Services' Q1 2026 earnings growth dampened by volume hits
Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance

Payers and providers felt the upheaval and instability on the Affordable Care Act exchanges in the first quarter of this year.
Marketplace plans saw significant enrollment declines alongside tier shifts, while providers felt the impact in both volumes and payer mix.
Fierce Healthcare's Dave Muoio and Paige Minemyer sit down this week on &ldquo;Podnosis&rdquo; to break down those trends and other first-quarter throughlines, including the effect of winter storms on provider finances and signs of a rebound in Medicare Advantage.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/finance/aca-exchanges-dominated-q1-earnings-calls-heres-what-payer-health-system-execs-had-say">The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/tenet-healthcare-paces-ahead-earnings-despite-q1s-volume-curveballs">Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/cigna-posts-165b-profit-q1-earnings-beat">Cigna to exit ACA market, pursue strategic alternatives for eviCore unit</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/universal-health-services-q1-2026-earnings-growth-dampened-volume-hits">Universal Health Services' Q1 2026 earnings growth dampened by volume hits</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/centene-raises-2026-guidance-strong-q1-revenue-earnings-results">Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/hca-healthcare-executives-shrug-q1-volumes-disruptions-reaffirm-fy2026-guidance">HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance</a></li>
</ul>

An insider’s look at LillyDirect

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips